centocor
(2)
Dan Baker
Dan Baker is a physician-scientist turned biotech founder who spent two decades at Johnson & Johnson's Janssen division helping bring immunology blockbusters Remicade, Simponi and Stelara to patients, before launching Brisbane-based Kira Biotech in 2019 as its founding CEO. Kira is developing KB312, a first-in-class antibody designed to selectively retrain the immune system rather than broadly suppress it, aimed at autoimmune diseases such as rheumatoid arthritis, lupus and type 1 diabetes. A rheumatologist who taught at the University of Pennsylvania for 18 years, Baker also advises drug-development organisations and serves as a healthcare venture partner.
Bobba Venkatadri
Bobba Venkatadri is a General Partner at Ventureast and founder of the DigiLife fund, investing in life sciences and healthcare across India and the US. A pharmacist by training with four decades of operating experience at companies like Warner Lambert, Centocor, Molecular Biosystems, and Aradigm, he sits on the boards of multiple portfolio companies and quietly runs a soybean farm on the side.